Dgke Variants Cause A Glomerular Microangiopathy That Mimics Membranoproliferative Gn
Tarih
2013Yazar
Özaltın, Fatih
Li, Binghua
Rauhauser, Alysha
An, Sung-Wan
Söylemezoğlu, Oğuz
Gönül, İpek Işık
Taşkıran, Ekim Z.
İbsirlioglu, Tülin
Korkmaz, Emine
Bilginer, Yelda
Duzova, Ali
Özen, Seza
Topaloğlu, Rezan
Beşbaş, Nesrin
Ashraf, Shazia
Du, Yong
Liang, Chaoying
Chen, Phylip
Lu, Dongmei
Vadnagara, Komal
Arbuckle, Susan
Lewis, Deborah
Wakeland, Benjamin
Quigg, Richard J.
Ransom, Richard F.
Wakeland, Edward K.
Topham, Matthew K.
Bazan, Nicolas G.
Mohan, Chandra
Hildebrandt, Friedhelm
Bakkaloglu, Aysin
Huang, Chou-Long
Attanasio, Massimo
Üst veri
Tüm öğe kaydını gösterÖzet
Renal microangiopathies and membranoproliferative GN (MPGN) can manifest similar clinical presentations and histology, suggesting the possibility of a common underlying mechanism in some cases. Here, we performed homozygosity mapping and whole exome sequencing in a Turkish consanguineous family and identified DGKE gene variants as the cause of a membranoproliferative-like glomerular microangiopathy. Furthermore, we identified two additional DGKE variants in a cohort of 142 unrelated patients diagnosed with membranoproliferative GN. This gene encodes the diacylglycerol kinase DGK epsilon, which is an intracellular lipid kinase that phosphorylates diacylglycerol to phosphatidic acid. Immunofluorescence confocal microscopy demonstrated that mouse and rat Dgk epsilon colocalizes with the podocyte marker WT1 but not with the endothelial marker CD31. Patch-clamp experiments in human embryonic kidney (HEK293) cells showed that DGK epsilon variants affect the intracellular concentration of diacylglycerol. Taken together, these results not only identify a genetic cause of a glomerular microangiopathy but also suggest that the phosphatidylinositol cycle, which requires DGKE, is critical to the normal function of podocytes. J Am Soc Nephrol 24: 377-384, 2013. doi: 10.1681/ASN.2012090903